Get started
Award

Health-f2-2009-223175

Funded outputs count: 349
Funder award ID: HEALTH-F2-2009-223175
OpenAlex ID: G751661945
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026 · Hagai Levi, Qin Wang, et al. · medRxiv
PDF
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium
2026 · Nicola S. Meagher, Kami K. White, et al. · British Journal of Cancer
PDF
Comparative fine-mapping of breast cancer susceptibility loci using summary statistics methods and multinomial regression
2026 · Denise G. O’Mahony, Jonathan Beesley, et al. · medRxiv
PDF
Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis
2026 · Nasim Mavaddat, Daniel R. Barnes, et al. · British Journal of Cancer
PDF
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
2026 · Jason L. Vassy, Anna M. Dornisch, et al. · Nature Cancer · 8
A reanalysis of a genome-wide association study on breast cancer in Asian populations using the SG10K_Health reference panel for imputation: a multi-Centre case–control analysis
2026 · Xuling Chang, Shivaani Mariapun, et al. · Human Molecular Genetics
Cell-type aware transcriptome-wide association study of mammographic density phenotypes
2025 · Adriana Sistig, Joseph H Rothstein, et al. · medRxiv
PDF
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025 · Daniel R. Barnes, Jonathan P. Tyrer, et al. · npj Genomic Medicine · 1
PDF
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025 · Barnes, Daniel R, Tyrer, Jonathan P, et al. · eScholarship (California Digital Library)
PDF
Causal plasma metabolites for breast cancer risk: a two-sample Mendelian randomization study with colocalization evidence
2025 · Hanghang Chen, Yueyuan Xu, et al. · Discover Oncology
PDF
Assessing the causal and independent impact of parity-related reproductive factors on risk of breast cancer subtypes
2025 · Claire Prince, Laura D. Howe, et al. · BMC Medicine · 2
PDF
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers
2025 · Mei-Chee Tai, Joe Dennis, et al. · npj Breast Cancer · 5
PDF
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis
2025 · Emma Hazelwood, Lucy J Goudswaard, et al. · JNCI Journal of the National Cancer Institute · 6
PDF
Blood lipids and prostate cancer: a Mendelian randomization analysis
2025 · Bull CJ, Bonilla C, et al. · UTUPub (University of Turku)
PDF
Novel Shared Heritable Candidate Risk Loci of Breast and Endometrial Cancer—A Swedish Haplotype Genome-Wide Association Study
2025 · Elin Barnekow, Wen Liu, et al. · International Journal of Molecular Sciences
PDF
Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study
2025 · Renée MG Verdiesen, Mehrnoosh Shokouhi, et al. · Cancer Epidemiology Biomarkers & Prevention · 3
PDF
Interactions between genetic and epidemiological factors influencing mammographic density
2025 · Austin Hammermeister Suger, Hongjie Chen, et al. · American Journal of Epidemiology
PDF
A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer risk
2025 · Elin Barnekow, Wen Liu, et al. · PLoS ONE · 2
Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries
2025 · Peh Joo Ho, Christine Kim Yan Loo, et al. · medRxiv
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
2025 · Reiner Hoppe, Stefan Winter, et al. · npj Breast Cancer · 1
PDF
Complex Role of Circulating Triglycerides in Breast Cancer Onset and Survival: Insights From Two‐Sample Mendelian Randomization Study
2025 · Wu Zhang, Zhiru Li, et al. · Cancer Medicine · 3
PDF
Polygenic risk scores stratify breast cancer risk among women with benign breast disease
2024 · Mark E Sherman, Stacey J Winham, et al. · JNCI Journal of the National Cancer Institute · 7
PDF
Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers
2024 · Joon Ho Kang, Youngkee Lee, et al. · Communications Biology · 9
Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes
2024 · Carlos G. Urzúa-Traslaviña, Tijs van Lieshout, et al. · BMC Medical Genomics · 4
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
2024 · Trishna A. Desai, Åsa K. Hedman, et al. · EBioMedicine · 27
Year
Topic